Lab tests aim to tailor cancer treatments for patients who've run out of options
NCT ID NCT06024603
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether doctors can quickly recommend personalized cancer treatments for adults whose cancers have returned or stopped responding to standard therapy. Researchers will take a sample of the tumor, test it against many drugs in the lab, and also analyze its genes. The goal is to see if they can provide a ranked list of treatment options within 4 weeks for at least 22 out of 36 participants. This approach could help match patients to drugs that might work better for their specific cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Drug Sensitivity Test (DST) and genomic profiling
What this could lead to
If successful, this could pave the way for personalized cancer treatments tailored to each patient's tumor, potentially improving outcomes for those with limited options.
What could go wrong
This is a small, early feasibility study (36 participants) focused on whether recommendations can be made in time, not on effectiveness. The approach may not work for all cancer types or may not improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Florida International University
Miami, Florida, 33199, United States
-
Lerner College of Medicine, Cleveland Clinic Florida
Weston, Florida, 33331, United States